Focus topics


Feature
•

China approves first mRNA vaccine

Beijing did not want to be dependent on foreign companies like BioNTech and therefore waited a long time before granting the first approval. The race has now been won by the domestic company CPSC.

China has approved its first mRNA vaccine after a long wait. On Wednesday, the Chinese company CSPC Pharmaceutical announced on the Hong Kong stock exchange that it had received emergency approval for its mRNA vaccine developed against the Omicron variant. The company, based in Shijiazhuang, Hebei province, did not initially provide details on when the vaccine would be used in Chinese vaccination centers and hospitals.

Continue reading now

… and get free access to this Professional Briefing for a month.

Continue free reading

Are you already a guest at the China.Table? Log in now

Related

    Hong Kong: Low minimum wage threatens social stability
    Slow recovery leaves German company disappointed
    Power of Siberia 2 is not making progress
    ‘Marriage and birth culture’ to combat aging population
Be our guest at the China.Table. Try it for free now, no automatic renewal.
Try it for free